Cardiovascular Outcomes and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Current Data and Future Prospects

Duprez DA, Handelsman Y, Koren M

Vascular Health and Risk Management 2020, 16:403-418

Published Date: 7 October 2020